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Ovarian hyperstimulation syndrome (OHSS) is a disturbing compli-
cation in infertility treatment. OHSS treatments aim to reduce vascular
permeability, and include antiprostaglandin, anti vascular endothelial
growth factor (VEGF), dopamine agonist and inhibition of VEGFR-2
phosphorylation (SU5416) (Soares et al., 2008). We wish to draw
attention to a recent case of ours, a giant perforated duodenal ulcer,
an extremely rare associated disorder of OHSS. Only one similar
case has been reported previously (Uhler et al., 2001). Psychological
stress from infertility and IVF may be instrumental in inducing peptic
ulcers (Reed, 2002), and therefore prophylactic treatment of stress
ulcers is critical in hyperstimulation situations (Barletta et al., 2002).
We recently treated a 30-year-old nulligravid woman with amenor-
rhea and infertility (.8 years). She had no history of serious clinical
illness, clinical examination was normal; she had normal hysterosalpin-
gography and slight galactorrhoea, ultrasonic pelvic examination
showed a small uterus, endometrial diameter of 3 mm and normal
ovaries. Laboratory data showed slightly increased serum level of
prolactin (601 mIU/ml).
A treatment regime, Cabergoline 0.5 mg twice per week and
human menopausal gonadotrophin (hMG) 225 IU per day for
6 days, was begun. Vaginal ultrasound at Day 7 showed numerous
small follicles with the largest diameter of 13 mm. In order to
prevent hyperstimulation syndrome, human chorionic gonadotrophin
(hCG) administration was retarded for 4 days and she received only
one ampoule 75 IU hMG every other day. In total, 20 hMG ampoules
(18 þ 2) were administered, and after 4 days 5000 hCG was injected.
Three days after injection of hCG, patient was admitted in hospital
with abdominal pain and vomiting. Blood examination showed WBC
14 900/ml, haemoglobin 14.5 g/dl, hematocrit 45.2%, platelet count
250 000/ml albumin 4 g/l, creatinine 1.5 mg/dl.
Abdominal ultrasound demonstrated large ovaries (12–13 cm) with
numerous follicles and some fluid in the posterior cul-de-sac. One day
after admission she was transferred to intensive care unit (ICU)
because of cyanosis and severe abdominal pain. Peritoneal fluid was
aspirated under abdominal ultrasound guide, which contained elevated
protein (8 g/dl), WBC (2000/ml), RBC (2200/ml) counts. She devel-
oped upper mid abdominal pain on the seventh day, and her status
continued to deteriorate. High fever appeared 2 days after ICU admis-
sion. Patient was intubated and mechanical ventilation started immedi-
ately. A laparotomy was performed to investigate cystic ovarian
torsion or rupture of ovary. Little fluid was detected in abdomen,
ovaries were large and very soft, the right ovary contained a yellowish
fluid, and no rupture or torsion and no injured intestine was observed.
A large fragment of the ovaries were removed and a pelvic drain was
inserted. Three to four days after laparotomy large volume of yellow
discharge from the abdominal drain was observed, and after opaque
meal X-ray, duodenal perforation was diagnosed. A surprising, 3–
4 cm, giant perforated duodenal ulcer in anterior wall of duodenum
was observed in the second laparotomy. A large drain was inserted
into the duodenum via the ulcer opening, and another one was left
in the peritoneum close to the ulcer to collect the probable remaining
secretions (Gupta et al., 2005).
Despite broad spectrum antibiotic therapy, high fever continued
25 days after the operation. Forty eight days after arrival, a third lapar-
otomy was performed but after 2 h the patient died.
In the final week, the patient developed symptoms of disseminated
intravascular coagulation, hematuria and low platelet count.
To our knowledge, only one previous case of duodenal perforation
with critical OHSS has been reported (Uhler et al., 2001). This case
thus poses the question; should stress ulcer and duodenal perforation
be included in complications of OHSS or not?
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Diagnosis and treatment were, in this case, delayed because the
occurrence of a duodenal perforation was not initially considered
for a number of reasons: (i) abdominal pain, large tender abdomen,
tachypnea and tachycardia are the cardinal signs of OHSS, and it is
very difficult to distinguish it from other acute abdomen causes
especially duodenal perforation, and (ii) peritoneal fluids in both con-
ditions are similar, and yellow in colour.
In our patient on the second day in ICU high fever appeared.
High fever is an important symptom of duodenal perforation (Gupta
et al., 2005) but it may be a symptom of peritonitis caused from
needle contamination or perforation of intestine in the time of
ovum extraction or ascites aspiration. One case of OHSS and perfo-
rated appendicitis was reported in 2003 with high fever (Fujimoto
et al., 2002).
A multicentre study reviewing OHSS patients showed that febrile
morbidity among severe and critical OHSS patients was remarkably
high, affecting 83.3% of all patients (Abramov et al., 1998).
Thus, accurate diagnosis is very complicated and, in this case, diag-
nosis was made on the basis of large quantity of discharge from her
abdominal drain. Ovarian reduction surgery or partial oophorectomy
(Amarin, 2003), such as that performed in this patient, is not rec-
ommended unless in a critical patient. Instead of wedge resection or
partial oophorectomy, bilateral complete oophorectomy may be
inevitable.
This letter highlights the importance of physician attention and
careful monitoring of patients after ovarian stimulation for early detec-
tion of any possible complication, particularly patients with OHSS.
We propose that duodenal perforation should be considered as
one of the associated complications of OHSS, and suggest that clini-
cians pay particular attention to this when, despite surgery and inten-
sive medical care, the patient does not stabilize and abdominal pain
continues. In our case, had we known of this complication, we
might have saved the life of this patient.
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Does the estradiol level on the
day of human chorionic
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We read with interest the article of Kyrou et al. (2009). The authors
prospectively evaluated the impact of E2 exposure on clinical preg-
nancy rates (PR) in 207 patients undergoing assisted conception treat-
ment with GnRH antagonist protocol. Categorising patients according
to E2 percentiles instead of arbitrary chosen cut-off E2 levels adds
value to the design of the study. At the end, the authors concluded
that elevated E2 levels could have a deleterious effect on endometrial
receptivity. However, it is not clear how the authors came to this
conclusion based on their results. Their analyses revealed that
neither implantation rates (IR) nor PR differed according to the E2 per-
centile category of the patients assessed. Although a subgroup analysis
of their data revealed statistically higher E2 levels among non-pregnant
cases in high responders, the number of patients are too low (51
patients) to draw a conclusion. Moreover the subgroups they analysed
were not homogenous such as more ICSI cycles and higher progester-
one levels were observed in the non-pregnant hyperresponder group.
Therefore, we assume that authors’ null hypothesis should have been
‘elevated E2 levels were better correlated with higher PR’ and their
null hypothesis was rejected because of the results achieved in the
current study.
The authors discussed several articles addressing elevated E2 levels
and its impact on endometrium and clinical outcome. On the other
hand, they did not recognise recent relevant articles (Bahceci et al.,
2006; Ulug et al., 2006). These two studies retrospectively evaluated
more than 5000 GnRH agonist down-regulated ICSI–embryo transfer
cycles according to the E2 percentiles on the day of hCG and did not
find adverse impact of high E2 levels on the clinical outcome in terms
of IR, PR and both subclinical and clinical pregnancy losses. Hence
inferior PR were correlated to lower E2 levels. It is of note that
severe OHSS due to exaggerated E2 levels should be ruled out as it
was an exclusion criteria in the current study.
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